Acute effects of lamotrigine (BW430C) in persons with epilepsy.
Sixteen epileptic patients took single doses of lamotrigine, 120 mg or 240 mg. Six photosensitive patients showed reduction (with abolition in two) in photosensitivity after lamotrigine administration. Five subjects with frequent interictal spikes showed reduction in spike frequency over 24 h after lamotrigine administration. The half-life (t1/2) of lamotrigine in subjects taking sodium valproate was prolonged, whereas the t1/2 in subjects taking carbamazepine and/or phenytoin was reduced. The area under the curve of co-medication plasma levels was not affected by a single dose of lamotrigine. Five patients reported mild and generally transitory side effects; some of which represented exacerbation of preexisting complaints.
Binnie
C D
CD
van Emde Boas
W
W
Kasteleijn-Nolste-Trenite
D G
DG
de Korte
R A
RA
Meijer
J W
JW
Meinardi
H
H
Miller
A A
AA
Overweg
J
J
Peck
A W
AW
van Wieringen
A
A
D000293:Adolescent; D000328:Adult; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D006207:Half-Life; D006801:Humans; D000077213:Lamotrigine; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D010787:Photosensitivity Disorders / Q000139:chemically induced; D014227:Triazines / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use
D014227:Triazines; D000077213:Lamotrigine